Frontier Biotechnologies Inc. (SHA:688221)
China
· Delayed Price · Currency is CNY 21.10
-0.40 (-1.86%)
At close: Apr 29, 2026
Frontier Biotechnologies Revenue
Frontier Biotechnologies had revenue of 297.13M CNY in the quarter ending March 31, 2026, with 948.89% growth. This brings the company's revenue in the last twelve months to 392.19M, up 194.54% year-over-year. In the year 2025, Frontier Biotechnologies had annual revenue of 123.39M, down -4.70%.
Revenue (ttm)
392.19M
Revenue Growth
+194.54%
P/S Ratio
20.15
Revenue / Employee
1.30M
Employees
524
Market Cap
7.90B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Lukang Pharmaceutical | 5.71B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.14B |
| Jiuzhitang | 2.23B |
| Shenzhen Neptunus Bioengineering | 27.28B |
| Sichuan Huiyu Pharmaceutical | 1.03B |
| Hunan Er-Kang Pharmaceutical | 1.06B |
| Zhejiang Xianju Pharmaceutical | 3.76B |